On May 16 in New York, Endpoints News and the Financial Times are teaming up to host the US Pharma and Biotech Summit.
I’ve been deeply involved in planning our interviews and panels, and we have a fantastic program about artificial intelligence, different approaches to the US longevity crisis, the battle over who owns the relationship with patients, the macro economy and its impact on investments and dealmaking, and more. And we’ll feature panels with top executives and leaders from the FTC and FDA, Biogen, GSK, Goldman Sachs, Ro, and Eikon.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.